Lucentia FACE
A clinical system for regenerative biorevitalization based on the synergy of PDRN and hyaluronic acid to restore the quality and clarity of facial skin. It is targeted at true biological regeneration, improving the integrity of the extracellular matrix, and progressive cell renewal without creating an artificial volume effect.
The product triggers a tissue regeneration cascade through a balanced combination of biostimulating nucleotides and hydrating molecules. Polydeoxyribonucleotide (PDRN) acts as a nucleoside donor, activating cellular repair and regeneration signaling. Concurrently, medium-molecular-weight hyaluronic acid retains moisture in the intercellular space, stabilizes the extracellular matrix, and protects collagen fibers from degradation. The remodeling process occurs physiologically, restoring elasticity and firmness to the tissues.
The product triggers a tissue regeneration cascade through a balanced combination of biostimulating nucleotides and hydrating molecules. Polydeoxyribonucleotide (PDRN) acts as a nucleoside donor, activating cellular repair and regeneration signaling. Concurrently, medium-molecular-weight hyaluronic acid retains moisture in the intercellular space, stabilizes the extracellular matrix, and protects collagen fibers from degradation. The remodeling process occurs physiologically, restoring elasticity and firmness to the tissues.
Fill in the fields and we will contact you!
Please check the correctness of your phone number before submitting the application!
Download the files and learn more about the product
Indications for use
Recommended for non-volumetric regenerative therapy and restoration of the structural potential of the skin:
Composition:
Release form:
Recommended for non-volumetric regenerative therapy and restoration of the structural potential of the skin:
- General deterioration of quality, flaccidity and loss of elasticity of the dermis.
- Manifestations of early aging, the presence of static and mimic fine wrinkles.
- Dull, dehydrated and opaque skin with lost natural radiance.
- Maintenance, repair and accelerated post-procedural tissue recovery.
Composition:
- Sterile, isotonic and biocompatible system with physiological parameters for maximum clinical comfort:
- PDRN (Polydeoxyribonucleotide from salmon DNA): 10 mg per 2 ml syringe (working concentration - 5 mg/ml).
- Medium molecular weight hyaluronic acid: 40 mg per 2 ml syringe (working concentration - 20 mg/ml).
Release form:
- Package: 1 pre-filled sterile syringe with a volume of 2 ml.
- Active formula volume: 2 ml of solution containing a total of 50 mg of active regenerative substances optimized for the treatment of the entire facial area.